1st Quarter 2023
Key topics in this quarter’s edition include:
- Arexvy and Abrysvo vaccines for respiratory syncytial virus (RSV) infection in adults ≥ 60 years
- Delandistrogene moxeparvovec (gene therapy) for treatment of Duchenne muscular dystrophy (DMD)
- Obeticholic acid for treatment of nonalcoholic steatohepatitis (NASH)
Top